Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flow from operating activities:
Net loss	$ (7,400,104)	$ (7,345,170)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	326,730	417,989
Vesting expense	1,040	15,159
Common stock issued to non-employees	99,253	79,280
(Gain) on derivative instruments	(1,368)	(8,261)
Loss on impairment of property and equipment	0	162,905
Loss on disposal of property and equipment	20,205	903
Inventories
Accounts receivable	(53,343)	(99,653)
Inventories	(73,841)	36,795
Prepaid expense and other assets	(73,024)	47,090
Accounts payable	220,996	66,109
Accrued expenses and other	329,330	(401,002)
Contract liabilities	(38,148)	25,823
Other long-term liabilities	8,202	0
Net cash (used in) operating activities:	(6,634,072)	(7,002,033)
Cash flow from investing activities:
Purchase of property and equipment	(9,510)	(279,727)
Acquisition of intangibles	(0)	26,018
Net cash (used in) investing activities:	(9,510)	(305,745)
Cash flow from financing activities:
Proceeds from issuance of common stock	3,695,848	0
Costs to issue common stock	(573,846)	0
Proceeds from issuance of financing note payable	275,098	0
Repayment of note payable	(150,408)	0
Net cash provided by financing activities	3,246,692	0
Net (decrease) in cash	(3,396,890)	(7,307,778)
Cash and cash equivalents at beginning of period	8,728,660	22,071,523
Cash and cash equivalents at end of period	5,331,770	14,763,745
Supplemental disclosure for cash flow information:
Cash payments for interest	1,737	0
Non-cash transactions:
Right-of-use assets obtained in exchange for lease liabilities	0	2,997,181
Series F Preferred Stock dividend	0	794
Common stock issued to settle accrued board of directors’ and advisory boards’ compensation	0	189,896
Purchase of property & equipment accrued in accounts payable	0	3,920
Redemption of Series F Preferred Stock	0	794
Reverse Stock Split [Member]
Non-cash transactions:
Common stock issued to settle accrued board of directors’ and advisory boards’ compensation	$ 0	$ 253